View Clinical Trial (Medical Research Study)
A Prospective Comparison of Low Dose Hydroxychloroquine and Phlebotomy in the Treatment of Porphyria Cutanea Tarda
| City: |
|
Galveston |
| State: |
|
Texas |
| Zip Code: |
|
77555 |
| Conditions: |
|
Porphyria Cutanea Tarda |
| Purpose: |
|
Porphyria cutanea tarda (PCT) is an iron-related disorder that responds to treatment by
phlebotomy or low-dose hydroxychloroquine, but comparative data on these treatments are
limited. The hypothesis is that hydroxychloroquine is noninferior to phlebotomy in terms of
time to remission. Patients with well documented PCT are assigned to treatment by
randomization if specific criteria are met. All patients are followed until remission -
defined as achieving a normal plasma porphyrin concentration.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Documented porphyria cutanea tarda (PCT)
- Willing to give informed consent
- Age 18 or greater
Exclusion Criteria:
- Blistering skin lesions due to another condition
|
| NCT ID: |
|
NCT01573754 |
| Primary Contact: |
|
N/A |
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Galveston, Texas 77555
United States
Karl E Anderson, MD
Phone: 409-772-4661
Email: kanderso@utmb.edu
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 18, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|